Integrated Filing — IndAS



General information about company

Scrip Code 544067
NSE Symbol INNOVACAP
MSEI Symbol NOTLISTED
ISIN INE0DUT01020
Name of company INNOVA CAPTAB LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 21-08-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 18-08-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Drugs and Pharmaceutical products
Start date and time of board meeting 21-08-2026   23:16:00
End date and time of board meeting 22-08-2026   00:25:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
1 Income
Revenue from operations 44,780.20 1,63,001.80
Other income 156.40 742.00
Total income 44,936.60 1,63,743.80
2 Expenses
(a) Cost of materials consumed 26,123.70 1,00,546.30
(b) Purchases of stock-in-trade 3,258.20 5,833.30
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 283.70 (1,100.20)
(d) Employee benefit expense 4,261.50 16,720.40
(e) Finance costs 459.30 1,689.80
(f) Depreciation, depletion and amortisation expense 1,138.80 4,517.90
(f) Other Expenses
1 Power and fuel 981.80 3,911.70
2 Packing charges 524.00 1,965.80
3 Stores and spares consumed 479.60 1,922.80
4 Travelling and conveyance 369.40 1,331.20
5 Repairs and maintenance 346.00 1,317.10
6 Freight charges 516.70 1,299.50
7 Commission on sales 320.90 1,152.30
8 Rates, fees and taxes 207.40 658.50
9 Sales promotion expense 217.20 623.30
10 Miscellaneous expenses 380.90 2,527.70
Total other expenses 4,343.90 16,709.90
Total expenses 39,869.10 1,44,917.40
3 Total profit before exceptional items and tax 5,067.50 18,826.40
4 Exceptional items 0.00 0.00
5 Total profit before tax 5,067.50 18,826.40
6 Tax expense
7 Current tax 441.00 2,558.70
8 Deferred tax 591.60 1,949.40
9 Total tax expenses 1,032.60 4,508.10
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 4,034.90 14,318.30
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 4,034.90 14,318.30
17 Other comprehensive income net of taxes 24.40 40.60
18 Total Comprehensive Income for the period 4,059.30 14,358.90
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 0.00 0.00
Total profit or loss, attributable to non-controlling interests 0.00 0.00
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 0.00 0.00
Total comprehensive income for the period attributable to owners of parent non-controlling interests 0.00 0.00
21 Details of equity share capital
Paid-up equity share capital 5,722.50 5,722.50
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve 1,02,428.90
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 7.05 25.02
Diluted earnings (loss) per share from continuing operations 7.05 25.02
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 7.05 25.02
Diluted earnings (loss) per share from continuing and discontinued operations 7.05 25.02
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) 1 The above revised consolidated financial results of Innova Captab Limited the Company or the Holding Company and its subsidiaries Holding and its subsidiaries together referred to as the Group have been prepared in accordance with and comply in all material aspects with the Indian Accounting Standards Ind AS notified under Section 133 of the Companies Act 2013 the act read with relevant rules issued there under and in terms of Regulation 33 of Securities and Exchange Board of India Listing Obligations and Disclosure Requirements Regulations 2015 Listing Regulation as amended The revised consolidated financial results for the quarter and year ended 31 March 2026 are available on the Company website ie www.innovacaptab.com under investor information section and on the stock exchange websites ie www.nseindia.com and www.bseindia.com. 2. The Audit Committee had reviewed and recommended the consolidated financial results of the Group for the quarter and year ended 31 March 2026 in their meeting held on 7 May 2026 referred to as original consolidated financial results which had been approved and taken on record by the Board of Directors in their meeting on held on 7 May 2026 except for certain inadvertent errors as listed below i. Restatement of previous year financial information Deferred tax liability relating to fair value adjustments recognised as part of a historical business combination acquisition of Sharon Bio Medicine Limited had not been recognised in the consolidated financial results since the acquisition date 30 June 2023 As a consequence deferred tax assets net and other equity were overstated in the affected periods The error has been corrected retrospectively by restating each of the affected financial results captions for prior periods in accordance with requirements of Ind AS 8 The following tables summarizes the impacts on the Groups consolidated financial results Amount in rupees million except otherwise stated Statement of consolidated assets and liabilities as at 1 April 2024 Deferred Tax assets (net) As originally approved Rs 199.60 Adjustments Rs (105.37) As restated Rs 94.23 Total assets As originally approved Rs 13208.81 Adjustments Rs (105.37) As restated Rs 13103.44 Total liabilities As originally approved Rs 4899.87 As restated Rs 4899.87 Other equity As originally approved Rs 7736.69 Adjustments Rs (105.37) As restated Rs 7631.32 Total equity As originally approved Rs 8308.94 Adjustments Rs (105.37) As restated Rs 8203.57 Statement of Consolidated Assets and liabilities sheet as at 31 March 2025 Deferred Tax assets (net) As originally approved Rs 122.37 Adjustments Rs (115.44) As restated Rs 6.93 Total assets As originally approved Rs 15804.07 Adjustments Rs (115.44) As restated Rs 15688.63 Total liabilities As originally approved Rs 6209.90 As restated Rs 6209.90 Other equity As originally approved Rs 9021.92 Adjustments Rs (115.44) As restated Rs 8906.48 Total equity As originally approved Rs 9594.17 Adjustments Rs (115.44) As restated Rs 9478.73 Statement of Consolidated Financial results for the year ended 31 March 2025 Deferred Tax expense As originally approved Rs 159.80 Adjustments Rs 10.07 As restated Rs 169.87 Total Tax expense As originally approved Rs 427.58 Adjustments Rs 10.07 As restated Rs 437.65 Profit for the year As originally approved Rs 1282.58 Adjustments Rs (10.07) As restated Rs 1272.51 Total comprehensive income for the year As originally approved Rs 1285.23 Adjustments Rs (10.07) As restated Rs 1275.16 Basic and diluted earnings per equity share in Rs As originally approved Rs 22.41 Adjustments Rs (0.17) As restated Rs 22.24 Statement of Consolidated Financial results for the quarter ended 31 March 2025 Deferred Tax expense As originally approved Rs 57.91 Adjustments Rs 10.07 As restated Rs 67.98 Total tax expense As originally approved Rs 97.38 Adjustments Rs 10.07 As restated Rs 107.45 Profit for the period As originally approved Rs 295.73 Adjustments Rs (10.07) As restated Rs 285.66 Total comprehensive income for the period As originally approved Rs 299.45 Adjustments Rs (10.07) As restated Rs 289.38 Basic and diluted earnings per equity share in Rs As originally approved Rs 5.17 Adjustments Rs (0.18) As restated Rs 4.99 The correction of error has no impact on the total operating investing or financing cash flows for the year ended 31 March 2025 ii Revision of consolidated financial results for the year ended 31 March 2026 a Deferred tax asset of Rs 16.78 million on deduction available under section 80JJAA of Income tax Act 1961 has now been recognized in the Revised Statement Consolidated Assets and Liabilities with a corresponding adjustment to Revised Statement of Consolidated Financial Results Consequent to the above and the restatement mentioned in note 2(i) above, the relevant financial results captions for the year ended 31 March 2026 were revised as follows: Amount in Rupees millions except otherwise stated Statement of Consolidated Assets and Liabilities as at 31 March 2026 Deferred tax assets (net) As originally approved Rs 14.17 After revision rectify the error Rs 18.53 Total assets As originally approved Rs 18373.79 After revision rectify the error Rs 18378.14 Deferred tax liabilities (net) As originally approved Rs 242.65 After revision rectify the error Rs 339.78 Total liabilities As originally approved Rs 7465.87 After revision rectify the error Rs 7563 Other equity As originally approved Rs 10335.67 After revision rectify the error Rs 10242.89 Total equity As originally approved Rs 10907.92 After revision rectify the error Rs 10815.14 Statement of Consolidated Financial Results for the year ended 31 March 2026 Deferred Tax As originally approved Rs 217.60 After revision rectify the error Rs 194.94 Total tax expense As originally approved Rs 473.47 After revision rectify the error Rs 450.81 Profit for the year As originally approved Rs 1409.17 After revision rectify the error Rs 1431.83 Total comprehensive income for the year As originally approved Rs 1413.23 After revision rectify the error Rs 1435.89 Basic and diluted earnings per equity share in Rs As originally approved Rs 24.63 After revision rectify the error Rs 25.02 Statement of Consolidated Financial Results for the quarter ended 31 March 2026 Deferred Tax As originally approved Rs 81.82 After revision rectify the error Rs 59.16 Total tax expense As originally approved Rs 125.92 After revision rectify the error Rs 103.26 Profit for the year As originally approved Rs 380.83 After revision rectify the error Rs 403.49 Total comprehensive income for the period As originally approved Rs 383.27 After revision rectify the error Rs 405.93 Basic and diluted earnings per equity share in Rs As originally approved Rs 6.65 After revision rectify the error Rs 7.05 The correction of error has no impact on the total operating investing or financing cash flows for the year ended 31 March 2026 B Financial liabilities subject to supplier finance arrangements amounting to Rs 185.08 million have now been presented under other financial liabilities which were earlier presented as trade payables consequently, the relevant financial statement captions have been revised as below Amount in rupees million Statement of Consolidated Assets and Liabilities as at 31 March 2026 Trade payables total outstanding dues of creditors other than micro and small enterprises As originally approved Rs 2824.89 After revision to rectify the error Rs 2639.81 Other financial liabilities As originally approved Rs 280.49 After revision to rectify the error Rs 465.57 Total Current liabilities As originally approved Rs 4945.82 After revision to rectify the error Rs 4945.82 C The cash flows from operating activities were understated with a corresponding overstatement in cash flows from investing activities for fair value changes in current investments Further the cash flows from bank deposits made and proceeds from maturity of bank deposits within cash flows from investing activities were presented incorrectly and the adjustments relating to movements in inventories trade payables and other financial liabilities within cash flows from operating activities were presented incorrectly However these matters along with certain other immaterial changes do not have any impact on the amounts relating to net decrease in cash and cash equivalents during the year Consequently, the Statement of Consolidated Cash Flows has been revised as below Amount in rupees million Cash flows from operating activities for the year ended 31 March 2026 Adjustments for Fair value gain arising from financial instruments designated at FVTPL As originally approved Rs 0 After revision to rectify the error Rs (12.87) Provision/reversal of provision for obsolete inventory As originally approved Rs 22.82 After revision to rectify the error Rs 37.61 Working capital adjustments (Increase) in inventories As originally approved Rs (772.91) After revision to rectify the error Rs (787.70) Increase in trade payables As originally approved Rs 1183.27 After revision to rectify the error Rs 998.10 Increase in other financial liabilities As originally approved Rs 61.37 After revision to rectify the error Rs 246.45 Net cash generated from operating activities As originally approved Rs 1165.15 After revision to rectify the error Rs 1152.19 Cash flows from investing activities Purchase of current investments As originally approved Rs (412.85) After revision to rectify the error Rs (399.98) Bank deposit made As originally approved Rs (103.56) After revision to rectify the error Rs (751.40) Proceeds from maturity of bank deposits As originally approved Rs 30.81 After revision to rectify the error Rs 678.65 Net cash (used in) investing activities As originally approved Rs (1071.20) After revision to rectify the error Rs (1058.33) The above revisions together with certain clarificatory casting changes do not have any material impact on the profit total equity total assets or total liabilities and earnings per share of the Group as at and for the quarter / year ended 31 March 2026 The consolidated financial results have now been revised only to incorporate the necessary rectification relating to the above The revised consolidated financial results have been reviewed and recommended by Audit Committee at its meeting held on 21 August 2026 The Board of Directors at their meeting held on 22 August 2026 have approved the above results and taken them on record No other event occurring after 07 May 2026 being the date when the consolidated financial results were first approved by the Board of Directors has been considered for adjustment as a subsequent event The statutory auditors of the Company have expressed an unmodified opinion on the revised audited consolidated financial results for the quarter and year ended 31 March 2026 3 The Group comprise the following entities all of which have been incorporated in India Innova Captab Limited Holding Company Univentis Medicare Limited Wholly owned Subsidiary Company Sharon Bio Medicine Limited Step Down Subsidiary Company Univentis Foundation Subsidiary 4 The Government of India has consolidated 29 existing labour legislations into a unified framework comprising four Labour Codes viz Code on Wages 2019 Code on Social Security 2020 Industrial Relation Code 2020 and Occupational Safety Health and Working Condition Code 2020 collectively referred to as the New Labour Codes These Codes have been made effective from 21 November 2025 The Group has estimated and accounted liability related to gratuity and leave encashment in the financial results and expense for which is included in employee benefits expense The Group continues to monitor developments on the rules to be notified by regulatory authorities including clarifications additional guidance from authorities and will continue to assess the accounting implications basis such developments guidance 5 The Board of Directors of the Holding Company at their meeting held on 23 January 2026 has approved an interim dividend of Rs 2 per equity share face value Rs 10 per share 6 The Group has only one reportable segment ie Drugs and pharmaceutical products as per Ind AS 108 Operating Segments specified under section 133 of the Companies Act 2013 Accordingly the disclosures as per the listing agreement are not applicable to the group 7 The figures of the last quarter of the year ended 31 March 2026 and the corresponding quarter ended in the previous year as reported in these revised consolidated financial results are the balancing figures between revised audited figures in respect of full financial year and the unaudited published year to date figures up to the third quarter of the financial year Also the figures upto the end of the third quarter had only been reviewed and not subject to audit



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 31-03-2026
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 82,333.20
Capital work-in-progress 1,550.40
Investment property 0.00
Goodwill 1,669.40
Other intangible assets 148.30
Intangible assets under development 0.00
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 0.00
Non-current financial assets
Non-current investments 0.00
Trade receivables, non-current 0.00
Loans, non-current 39.40
Other non-current financial assets
1 Security Deposit 350.90
2 Balance with banks-deposits accounts with original maturity more than 12 months 3,807.80
Total of other non-current financial assets 4,158.70
Total non-current financial assets 4,198.10
Deferred tax assets (net) 185.30
Other non-current assets
1 Capital advances 1,248.10
2 Prepaid expenses 152.50
Total of other non-current assets 1,400.60
Total non-current assets 91,485.30
2 Current assets
Inventories 28,325.60
Current financial asset
Current investments 4,128.50
Trade receivables, current 43,728.60
Cash and cash equivalents 319.90
Bank balance other than cash and cash equivalents 67.00
Loans, current 43.90
Other current financial assets
Total of other current financial assets 8,692.70
Total current financial assets 56,980.60
Current tax assets (net) 0.00
Other current assets
1 Balances with government authorities 5,697.50
2 Advances to suppliers 648.80
3 Advances to employees 45.50
4 Prepaid expenses 334.00
5 Right to return goods 264.10
Total of other current assets 6,989.90
Total current assets 92,296.10
3 Non-current assets classified as held for sale 0.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 1,83,781.40
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 5,722.50
Other equity 1,02,428.90
Total equity attributable to owners of parent 1,08,151.40
Non controlling interest 0.00
Total equity 1,08,151.40
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 21,582.30
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities
Total of other non-current financial liabilities
Total non-current financial liabilities 21,582.30
Provisions, non-current 1,191.70
Deferred tax liabilities (net) 3,397.80
Deferred government grants, Non-current
Other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities 26,171.80
Current liabilities
Current financial liabilities
Borrowings, current 12,786.70
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 3,614.40
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 26,398.10
Total Trade payable 30,012.50
Other current financial liabilities
1 Interest accrued but not due on borrowings 113.10
2 Employee related payables 1,889.70
3 Capital Creditor - Total outstanding dues of other than micro and small enterprises 313.30
4 Unpaid dividend 0.20
5 Security Deposit 488.60
6 Supplier finance arrangements 1,850.80
Total of other current financial liabilities 4,655.70
Total current financial liabilities 47,454.90
Other current liabilities 1,258.00
1 Contract liabilities 651.20
2 Statutory dues 244.40
3 Refund Liability 362.40
Total of other current liabilities 1,258.00
Provisions, current 395.20
Current tax liabilities (Net) 350.10
Deferred government grants, Current
Total current liabilities 49,458.20
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 75,630.00
Total equity and liabilites 1,83,781.40
Disclosure of notes on assets and liabilities Textual Information(1)



Text Block

Textual Information(1) 1 Property plant and equipment includes amount of right of use of assets 2 Non current Borrowings include amount of lease liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-01-2026 01-04-2025
Date of end of reporting period 31-03-2026 31-03-2026
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments Textual Information(2)



Text Block

Textual Information(2) 1 The Company has only one reportable segment ie Drugs and pharmaceutical products as per Ind AS 108 Operating Segments specified under section 133 of the Companies Act 2013



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement of defined benefit obligation 31.90 54.30
2 Income tax relating to items that will not be reclassified to profit or loss (7.50) (13.70)
Total Amount of items that will not be reclassified to profit and loss 24.40 40.60
2 Income tax relating to items that will not be reclassified to profit or loss 0.00 0.00
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income 24.40 40.60



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 31-03-2026
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Consolidated
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 18,826.40
Adjustments for reconcile profit (loss)
Adjustments for finance costs 1,689.80
Adjustments for decrease (increase) in inventories (7,877.00)
Adjustments for decrease (increase) in trade receivables, current (10,426.50)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets (1,428.20)
Adjustments for decrease (increase) in other non-current assets (142.20)
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current (2,727.80)
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 9,981.00
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities (533.40)
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 4,517.90
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss (36.50)
Adjustments for provisions, current 227.50
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 2,464.50
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains (165.30)
Adjustments for dividend income 0.00
Adjustments for interest income 0.00
Adjustments for share-based payments 0.00
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 211.40
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) (4,244.80)
Net cash flows from (used in) operations 14,581.60
Dividends received 0.00
Interest paid 0.00
Interest received (434.30)
Income taxes paid (refund) 2,625.40
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 11,521.90
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 703.20
Purchase of property, plant and equipment 6,834.80
Proceeds from sales of investment property 0.00
Purchase of investment property 3,999.80
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 275.80
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (727.70)
Net cash flows from (used in) investing activities (10,583.30)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 3,361.20
Repayments of borrowings 2,722.30
Payments of lease liabilities 0.00
Dividends paid 1,144.30
Interest paid 1,657.30
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (7.90)
Net cash flows from (used in) financing activities (2,170.60)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (1,232.00)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents (1,232.00)
Cash and cash equivalents cash flow statement at beginning of period 1,551.90
Cash and cash equivalents cash flow statement at end of period 319.90





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 B S R & Co. LLP Yes 31-07-2028